SB0670 EnrolledLRB097 04433 RPM 44472 b

1    AN ACT concerning regulation.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 5. The Pharmacy Practice Act is amended by changing
5Section 26 as follows:
6    (225 ILCS 85/26)
7    (Section scheduled to be repealed on January 1, 2018)
8    Sec. 26. Anti-epileptic drug product selection prohibited.
9    (a) The General Assembly finds that this Section is
10necessary for the immediate preservation of the public peace,
11health, and safety.
12    (b) In this Section:
13    "Anti-epileptic drug" means (i) any drug prescribed for the
14treatment of epilepsy or (ii) a drug used to treat or prevent
16    "Epilepsy" means a neurological condition characterized by
17recurrent seizures.
18    "Seizure" means a brief disturbance in the electrical
19activity of the brain.
20    (c) When the prescribing physician has indicated on the
21original prescription "may not substitute", a pharmacist may
22not interchange an anti-epileptic drug or formulation of an
23anti-epileptic drug for the treatment of epilepsy without



SB0670 Enrolled- 2 -LRB097 04433 RPM 44472 b

1notification and the documented consent of the prescribing
2physician and the patient or the patient's parent, legal
3guardian, or spouse. This Section does not apply to medication
4orders issued for anti-epileptic drugs for any in-patient care
5in a licensed hospital.
6    (d) If a pharmacist substitutes any generic prescription in
7place of a brand-name anti-epileptic drug, then the pharmacist
8shall provide written notice to the patient no later than the
9time the prescription is dispensed.
10(Source: P.A. 94-936, eff. 6-26-06; 95-689, eff. 10-29-07.)